熱門資訊> 正文

ProMIS神经科学GAAP每股收益为-0.29美元

2025-08-13 22:27

ProMIS Neurosciences press release (NASDAQ:PMN): Q2 GAAP EPS of -$0.29.
Cash and cash equivalents were $4.5 million as of June 30, 2025, compared to $1.0 million as of June 30, 2024.

More on ProMIS Neurosciences

ProMIS Neurosciences raises $3.2M through ATM offering, PIPE financing
Seeking Alpha’s Quant Rating on ProMIS Neurosciences
Historical earnings data for ProMIS Neurosciences
Financial information for ProMIS Neurosciences

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。